Preservation of fertility in patients with cancer [11]

New England Journal of Medicine

Volumn 360, Issue 25, 2009, Pages 2681-

  Oktay, Kutluk ^a   Rodriguez Wallberg, Kenny ^b   Schover, Leslie ^c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LETROZOLE;

BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RECURRENCE; FERTILITY; GENE MUTATION; HUMAN; LETTER; MULTIPLE CYCLE TREATMENT; PRACTICE GUIDELINE; PRESERVATION; PRIORITY JOURNAL;

EID: 67449119193     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006;91:3885-3890 (Pubitemid 44536859)
2. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 2008;26:2630-2635
3. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000;342:1919. (Pubitemid 30419063)
4. Oktay K, Buyuk E, Veeck L, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;363:837-840 (Pubitemid 38368830)
5. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006;86:70-80. (Pubitemid 43962981)